Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma - Tomonari - 2020 - JGH Open - Wiley Online Library
Frontiers | Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
IJMS | Free Full-Text | Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology
Missoula Independent by Independent Publishing - Issuu
Microorganisms | Free Full-Text | The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen
Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis | Journal of Medicinal Chemistry